Diffuse Midline Glioma
general16
Centers
0
Active Trials
$42M
Cancer Funding
Specific Cancer Types(1)
| Name | Centers |
|---|---|
| Recurrent Diffuse Midline Glioma | 1 |
Top Centers for Diffuse Midline Glioma(16)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 69.5 |
| 2 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 67.3 |
| 3 | UCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, CA NCI Comprehensive Active Research Program | 65.2 |
| 4 | NCI Comprehensive Active Research Program | 63.0 |
| 5 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 60.8 |
| 6 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 58.6 |
| 7 | University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program | 56.4 |
| 8 | NCI Comprehensive Active Research Program | 54.2 |
| 9 | NCI Comprehensive Active Research Program | 52.0 |
| 10 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive Active Research Program | 49.8 |
| 11 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 47.7 |
| 12 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 45.5 |
| 13 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program | 43.3 |
| 14 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 41.1 |
| 15 | UK Markey Cancer CenterLexington, KY NCI Comprehensive Active Research Program | 38.9 |
| 16 | NCI Clinical Active Research Program | 36.7 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →